China Universal Asset Management Company’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.2K | Buy |
|
|||||
|
2025
Q1 | $31.5K | Sell |
|
|||||
|
2024
Q4 | $37.9K | Buy |
|
|||||
|
2024
Q3 | $67.9K | Buy |
|
|||||
|
2024
Q2 | $43.4K | Sell |
|
|||||
|
2024
Q1 | $109K | Buy |
|
|||||
|
2023
Q4 | $56.5K | Buy |
|
|||||
|
2023
Q3 | $9.46K | Buy |
|
|||||
|
2023
Q2 | $10.4K | Sell |
|
|||||
|
2023
Q1 | $7.98K | Buy |
|
|||||
|
2022
Q4 | $8.79K | Buy |
|
|||||
|
2022
Q3 | $17K | Buy |
|